{"id":327744,"date":"2025-08-01T05:40:00","date_gmt":"2025-08-01T05:40:00","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/why-is-pfizer-stock-so-low\/"},"modified":"2025-08-14T07:55:00","modified_gmt":"2025-08-14T07:55:00","slug":"why-is-pfizer-stock-so-low","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/","title":{"rendered":"Why is Pfizer Stock So Low: Analyzing the Decline of PFE"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\"><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":327308,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[28,45,44],"class_list":["post-327744","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trading","tag-investment","tag-stock","tag-strategy"],"acf":{"h1":"Why is Pfizer Stock So Low: 2025 Perspective","h1_source":{"label":"H1","type":"text","formatted_value":"Why is Pfizer Stock So Low: 2025 Perspective"},"description":"Why is Pfizer stock down? Discover the key factors behind PFE\u2019s price drop with timely analysis, hard data, and strategic investor insights from Pocket Option.","description_source":{"label":"Description","type":"textarea","formatted_value":"Why is Pfizer stock down? Discover the key factors behind PFE\u2019s price drop with timely analysis, hard data, and strategic investor insights from Pocket Option."},"intro":"Pfizer stock has dropped despite its pharma leadership. This article examines the main reasons behind the decline, including COVID-19 revenue loss, patent expirations, and market changes.","intro_source":{"label":"Intro","type":"text","formatted_value":"Pfizer stock has dropped despite its pharma leadership. This article examines the main reasons behind the decline, including COVID-19 revenue loss, patent expirations, and market changes."},"body_html":"<h2>Historical Trends: Pfizer\u2019s Stock Price Trajectory<\/h2>\r\nBetween 2020 and 2021, Pfizer stock surged \u2014 largely due to the success of its Comirnaty vaccine. But starting in 2022, the trend reversed.\r\n\r\n<strong>Pfizer vs. Market: Price Change Overview<\/strong>\r\n<table>\r\n<tbody>\r\n<tr>\r\n<th>Year<\/th>\r\n<th>Pfizer<\/th>\r\n<th>S&amp;P 500<\/th>\r\n<th>Pharma Sector<\/th>\r\n<\/tr>\r\n<tr>\r\n<td>2020<\/td>\r\n<td>+11.2%<\/td>\r\n<td>+16.3%<\/td>\r\n<td>+9.7%<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2021<\/td>\r\n<td>+60.4%<\/td>\r\n<td>+26.9%<\/td>\r\n<td>+18.2%<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2022<\/td>\r\n<td>\u201313.1%<\/td>\r\n<td>\u201319.4%<\/td>\r\n<td>\u20133.8%<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2023<\/td>\r\n<td>\u201344.5%<\/td>\r\n<td>+24.2%<\/td>\r\n<td>+2.6%<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2024<\/td>\r\n<td>\u201315.2%<\/td>\r\n<td>+9.8%<\/td>\r\n<td>\u20133.1%<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nAfter the pandemic-driven surge, market interest waned significantly. This is a major reason why Pfizer stock is so low.\r\n\r\n<img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1.png\" alt=\"\" width=\"1227\" height=\"765\" class=\"aligncenter wp-image-268871 size-full\" \/>\r\n<h2>Main Reasons Behind Pfizer\u2019s Decline<\/h2>\r\n<h3>1. Sharp Drop in COVID Revenue<\/h3>\r\nPfizer saw record earnings from its vaccine and Paxlovid in 2021\u20132022. But demand fell sharply post-pandemic.\r\n<table>\r\n<tbody>\r\n<tr>\r\n<th>Year<\/th>\r\n<th>COVID Revenue<\/th>\r\n<th>Total Revenue<\/th>\r\n<\/tr>\r\n<tr>\r\n<td>2021<\/td>\r\n<td>$36.8B<\/td>\r\n<td>$81.3B<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2022<\/td>\r\n<td>$56.7B<\/td>\r\n<td>$100.3B<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2023<\/td>\r\n<td>$12.5B<\/td>\r\n<td>$58.5B<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2024<\/td>\r\n<td>$8.0B<\/td>\r\n<td>$63.6B<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nInvestors now judge Pfizer by how well it can replace COVID-related revenues \u2014 a big reason why is PFE stock down.\r\n<h3>2. Patent Cliff and Generic Threats<\/h3>\r\nSeveral top-selling drugs are losing patent protection, paving the way for generics and revenue declines.\r\n<table>\r\n<tbody>\r\n<tr>\r\n<th>Drug<\/th>\r\n<th>Patent Expiry<\/th>\r\n<th>2023 Revenue<\/th>\r\n<th>Revenue Risk<\/th>\r\n<\/tr>\r\n<tr>\r\n<td>Eliquis<\/td>\r\n<td>2026<\/td>\r\n<td>$7.2B<\/td>\r\n<td>High<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Ibrance<\/td>\r\n<td>2027<\/td>\r\n<td>$4.9B<\/td>\r\n<td>Medium<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Xeljanz<\/td>\r\n<td>2025\u20132027<\/td>\r\n<td>$1.7B<\/td>\r\n<td>Medium<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Market Pressures<\/h2>\r\n<ul>\r\n \t<li>High interest rates penalize slower-growth stocks.<\/li>\r\n \t<li>U.S. drug pricing reforms (e.g., Medicare price negotiations) increase uncertainty.<\/li>\r\n \t<li>R&amp;D inefficiencies \u2014 rising development costs without proportional success rates.<\/li>\r\n \t<li>Capital outflows into tech and AI \u2014 traditional pharma struggles for attention.<\/li>\r\n<\/ul>\r\n<h2>Acquisitions and Market Reaction<\/h2>\r\nSince 2022, Pfizer has acquired several biotech firms to expand its pipeline \u2014 but investor response has been mixed.\r\n<table>\r\n<tbody>\r\n<tr>\r\n<th>Acquisition<\/th>\r\n<th>Year<\/th>\r\n<th>Price<\/th>\r\n<th>Sector<\/th>\r\n<\/tr>\r\n<tr>\r\n<td>Seagen<\/td>\r\n<td>2023<\/td>\r\n<td>$43B<\/td>\r\n<td>Oncology<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Arena Pharma<\/td>\r\n<td>2022<\/td>\r\n<td>$6.7B<\/td>\r\n<td>Immunology<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Biohaven<\/td>\r\n<td>2022<\/td>\r\n<td>$11.6B<\/td>\r\n<td>Neurology<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<strong>Challenges:<\/strong>\r\n<ul>\r\n \t<li>Premium deal prices<\/li>\r\n \t<li>Increased debt burden<\/li>\r\n \t<li>Short-term EPS dilution<\/li>\r\n<\/ul>\r\n<h2>Financial Overview: Is Pfizer Fundamentally Weak?<\/h2>\r\n<table>\r\n<tbody>\r\n<tr>\r\n<th>Metric<\/th>\r\n<th>2022<\/th>\r\n<th>2023<\/th>\r\n<th>2024<\/th>\r\n<\/tr>\r\n<tr>\r\n<td>Revenue<\/td>\r\n<td>$100.3B<\/td>\r\n<td>$58.5B<\/td>\r\n<td>$63.6B<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>EPS (Adj.)<\/td>\r\n<td>$6.58<\/td>\r\n<td>$1.84<\/td>\r\n<td>$2.38<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Free Cash Flow<\/td>\r\n<td>$29.3B<\/td>\r\n<td>$12.4B<\/td>\r\n<td>$14.1B<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Dividend<\/td>\r\n<td>$1.64<\/td>\r\n<td>$1.64<\/td>\r\n<td>$1.68<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nMassive drops in EPS and cash flow (\u201350%+) are key reasons why Pfizer stock is so low, despite a strong dividend.\r\n<h2>Future Outlook: Growth Potential vs. Risk<\/h2>\r\nPfizer\u2019s pipeline includes over 30 late-stage projects \u2014 from obesity drugs to RSV vaccines and cancer therapies.\r\n\r\n<strong>Top prospects:<\/strong>\r\n<ul>\r\n \t<li>Danuglipron (obesity, Phase 2, potential $10B+)<\/li>\r\n \t<li>Abrysvo (RSV vaccine, approved)<\/li>\r\n \t<li>Padcev (oncology, from Seagen deal)<\/li>\r\n<\/ul>\r\nStill, the market remains skeptical about Pfizer's ability to fully offset the lost COVID revenue.\r\n<h2>Pocket Option: Trading Opportunities on Pfizer<\/h2>\r\nLooking to trade the current PFE drop? Pocket Option offers flexible tools for short-term stock predictions:\r\n\r\n<strong>Available features:<\/strong>\r\n<ul>\r\n \t<li>Quick and Express trades on Pfizer<\/li>\r\n \t<li>Live PFE quotes<\/li>\r\n \t<li>Flexible timeframes (30 seconds to hours)<\/li>\r\n \t<li>Built-in indicators (RSI, MACD, EMA, etc.)<\/li>\r\n \t<li>No need to buy shares \u2014 trade price direction only<\/li>\r\n<\/ul>\r\n<img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en.png\" alt=\"\" width=\"1219\" height=\"765\" class=\"aligncenter wp-image-268880 size-full\" \/>\r\n\r\n<strong>Why use Pocket Option:<\/strong>\r\n<ul>\r\n \t<li>No broker account needed<\/li>\r\n \t<li>$5 minimum deposit (varies by method)<\/li>\r\n \t<li>$50,000 demo account to practice safely<\/li>\r\n<\/ul>\r\n&nbsp;\r\n\r\n<img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/02\/demo-trade-po-en.png\" alt=\"demo Pocket Option\" width=\"922\" height=\"592\" class=\"wp-image-261202 size-full aligncenter\" \/>\r\n\r\n[cta_green text=\"Try the $50,000 Demo Without Risk \ud83d\udca1\"]\r\n\r\nAdditional tools include:\r\n<ul>\r\n \t<li>News &amp; signals \u2014 get real-time Pfizer stock updates<\/li>\r\n \t<li>Social trading \u2014 follow top traders<\/li>\r\n \t<li>Analytics &amp; references \u2014 improve strategy with up-to-date data<\/li>\r\n \t<li>Video tutorials and strategy guides \u2014 apply proven methods to current conditions<\/li>\r\n<\/ul>\r\n<img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1.png\" alt=\"\" width=\"1896\" height=\"940\" class=\"aligncenter wp-image-272933 size-full\" \/>\r\n\r\n[cta_green text=\"Start Trading Pfizer Stock Today \ud83d\udcc9\"]\r\n<h2>Conclusion: What\u2019s Next for PFE?<\/h2>\r\nPfizer stock remains under pressure due to a combination of lost COVID revenue, patent cliffs, and merger-related losses. However, the company retains a stable balance sheet and is investing heavily in R&amp;D.\r\n\r\nWhy is Pfizer stock so low? The answer lies in both external market shifts and internal strategic headwinds.\r\n\r\n<strong>What to consider:<\/strong>\r\n<ul>\r\n \t<li>Dividend yield and long-term stability<\/li>\r\n \t<li>High short-term volatility risk<\/li>\r\n \t<li>Pipeline progress will be key for recovery<\/li>\r\n<\/ul>\r\nPocket Option allows traders to monitor these assets in real time and act on short-term movements with flexible trade setups.","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Historical Trends: Pfizer\u2019s Stock Price Trajectory<\/h2>\n<p>Between 2020 and 2021, Pfizer stock surged \u2014 largely due to the success of its Comirnaty vaccine. But starting in 2022, the trend reversed.<\/p>\n<p><strong>Pfizer vs. Market: Price Change Overview<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<th>Year<\/th>\n<th>Pfizer<\/th>\n<th>S&amp;P 500<\/th>\n<th>Pharma Sector<\/th>\n<\/tr>\n<tr>\n<td>2020<\/td>\n<td>+11.2%<\/td>\n<td>+16.3%<\/td>\n<td>+9.7%<\/td>\n<\/tr>\n<tr>\n<td>2021<\/td>\n<td>+60.4%<\/td>\n<td>+26.9%<\/td>\n<td>+18.2%<\/td>\n<\/tr>\n<tr>\n<td>2022<\/td>\n<td>\u201313.1%<\/td>\n<td>\u201319.4%<\/td>\n<td>\u20133.8%<\/td>\n<\/tr>\n<tr>\n<td>2023<\/td>\n<td>\u201344.5%<\/td>\n<td>+24.2%<\/td>\n<td>+2.6%<\/td>\n<\/tr>\n<tr>\n<td>2024<\/td>\n<td>\u201315.2%<\/td>\n<td>+9.8%<\/td>\n<td>\u20133.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>After the pandemic-driven surge, market interest waned significantly. This is a major reason why Pfizer stock is so low.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1.png\" alt=\"\" width=\"1227\" height=\"765\" class=\"aligncenter wp-image-268871 size-full\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1.png 1227w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1-300x187.png 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1-1024x638.png 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1-768x479.png 768w\" sizes=\"auto, (max-width: 1227px) 100vw, 1227px\" \/><\/p>\n<h2>Main Reasons Behind Pfizer\u2019s Decline<\/h2>\n<h3>1. Sharp Drop in COVID Revenue<\/h3>\n<p>Pfizer saw record earnings from its vaccine and Paxlovid in 2021\u20132022. But demand fell sharply post-pandemic.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Year<\/th>\n<th>COVID Revenue<\/th>\n<th>Total Revenue<\/th>\n<\/tr>\n<tr>\n<td>2021<\/td>\n<td>$36.8B<\/td>\n<td>$81.3B<\/td>\n<\/tr>\n<tr>\n<td>2022<\/td>\n<td>$56.7B<\/td>\n<td>$100.3B<\/td>\n<\/tr>\n<tr>\n<td>2023<\/td>\n<td>$12.5B<\/td>\n<td>$58.5B<\/td>\n<\/tr>\n<tr>\n<td>2024<\/td>\n<td>$8.0B<\/td>\n<td>$63.6B<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Investors now judge Pfizer by how well it can replace COVID-related revenues \u2014 a big reason why is PFE stock down.<\/p>\n<h3>2. Patent Cliff and Generic Threats<\/h3>\n<p>Several top-selling drugs are losing patent protection, paving the way for generics and revenue declines.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Drug<\/th>\n<th>Patent Expiry<\/th>\n<th>2023 Revenue<\/th>\n<th>Revenue Risk<\/th>\n<\/tr>\n<tr>\n<td>Eliquis<\/td>\n<td>2026<\/td>\n<td>$7.2B<\/td>\n<td>High<\/td>\n<\/tr>\n<tr>\n<td>Ibrance<\/td>\n<td>2027<\/td>\n<td>$4.9B<\/td>\n<td>Medium<\/td>\n<\/tr>\n<tr>\n<td>Xeljanz<\/td>\n<td>2025\u20132027<\/td>\n<td>$1.7B<\/td>\n<td>Medium<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Market Pressures<\/h2>\n<ul>\n<li>High interest rates penalize slower-growth stocks.<\/li>\n<li>U.S. drug pricing reforms (e.g., Medicare price negotiations) increase uncertainty.<\/li>\n<li>R&amp;D inefficiencies \u2014 rising development costs without proportional success rates.<\/li>\n<li>Capital outflows into tech and AI \u2014 traditional pharma struggles for attention.<\/li>\n<\/ul>\n<h2>Acquisitions and Market Reaction<\/h2>\n<p>Since 2022, Pfizer has acquired several biotech firms to expand its pipeline \u2014 but investor response has been mixed.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Acquisition<\/th>\n<th>Year<\/th>\n<th>Price<\/th>\n<th>Sector<\/th>\n<\/tr>\n<tr>\n<td>Seagen<\/td>\n<td>2023<\/td>\n<td>$43B<\/td>\n<td>Oncology<\/td>\n<\/tr>\n<tr>\n<td>Arena Pharma<\/td>\n<td>2022<\/td>\n<td>$6.7B<\/td>\n<td>Immunology<\/td>\n<\/tr>\n<tr>\n<td>Biohaven<\/td>\n<td>2022<\/td>\n<td>$11.6B<\/td>\n<td>Neurology<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Challenges:<\/strong><\/p>\n<ul>\n<li>Premium deal prices<\/li>\n<li>Increased debt burden<\/li>\n<li>Short-term EPS dilution<\/li>\n<\/ul>\n<h2>Financial Overview: Is Pfizer Fundamentally Weak?<\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>2022<\/th>\n<th>2023<\/th>\n<th>2024<\/th>\n<\/tr>\n<tr>\n<td>Revenue<\/td>\n<td>$100.3B<\/td>\n<td>$58.5B<\/td>\n<td>$63.6B<\/td>\n<\/tr>\n<tr>\n<td>EPS (Adj.)<\/td>\n<td>$6.58<\/td>\n<td>$1.84<\/td>\n<td>$2.38<\/td>\n<\/tr>\n<tr>\n<td>Free Cash Flow<\/td>\n<td>$29.3B<\/td>\n<td>$12.4B<\/td>\n<td>$14.1B<\/td>\n<\/tr>\n<tr>\n<td>Dividend<\/td>\n<td>$1.64<\/td>\n<td>$1.64<\/td>\n<td>$1.68<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Massive drops in EPS and cash flow (\u201350%+) are key reasons why Pfizer stock is so low, despite a strong dividend.<\/p>\n<h2>Future Outlook: Growth Potential vs. Risk<\/h2>\n<p>Pfizer\u2019s pipeline includes over 30 late-stage projects \u2014 from obesity drugs to RSV vaccines and cancer therapies.<\/p>\n<p><strong>Top prospects:<\/strong><\/p>\n<ul>\n<li>Danuglipron (obesity, Phase 2, potential $10B+)<\/li>\n<li>Abrysvo (RSV vaccine, approved)<\/li>\n<li>Padcev (oncology, from Seagen deal)<\/li>\n<\/ul>\n<p>Still, the market remains skeptical about Pfizer&#8217;s ability to fully offset the lost COVID revenue.<\/p>\n<h2>Pocket Option: Trading Opportunities on Pfizer<\/h2>\n<p>Looking to trade the current PFE drop? Pocket Option offers flexible tools for short-term stock predictions:<\/p>\n<p><strong>Available features:<\/strong><\/p>\n<ul>\n<li>Quick and Express trades on Pfizer<\/li>\n<li>Live PFE quotes<\/li>\n<li>Flexible timeframes (30 seconds to hours)<\/li>\n<li>Built-in indicators (RSI, MACD, EMA, etc.)<\/li>\n<li>No need to buy shares \u2014 trade price direction only<\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en.png\" alt=\"\" width=\"1219\" height=\"765\" class=\"aligncenter wp-image-268880 size-full\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en.png 1219w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en-300x188.png 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en-1024x643.png 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en-768x482.png 768w\" sizes=\"auto, (max-width: 1219px) 100vw, 1219px\" \/><\/p>\n<p><strong>Why use Pocket Option:<\/strong><\/p>\n<ul>\n<li>No broker account needed<\/li>\n<li>$5 minimum deposit (varies by method)<\/li>\n<li>$50,000 demo account to practice safely<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/02\/demo-trade-po-en.png\" alt=\"demo Pocket Option\" width=\"922\" height=\"592\" class=\"wp-image-261202 size-full aligncenter\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/02\/demo-trade-po-en.png 922w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/02\/demo-trade-po-en-300x193.png 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/02\/demo-trade-po-en-768x493.png 768w\" sizes=\"auto, (max-width: 922px) 100vw, 922px\" \/><\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Try the $50,000 Demo Without Risk \ud83d\udca1\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<p>Additional tools include:<\/p>\n<ul>\n<li>News &amp; signals \u2014 get real-time Pfizer stock updates<\/li>\n<li>Social trading \u2014 follow top traders<\/li>\n<li>Analytics &amp; references \u2014 improve strategy with up-to-date data<\/li>\n<li>Video tutorials and strategy guides \u2014 apply proven methods to current conditions<\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1.png\" alt=\"\" width=\"1896\" height=\"940\" class=\"aligncenter wp-image-272933 size-full\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1.png 1896w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1-300x149.png 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1-1024x508.png 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1-768x381.png 768w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/05\/strategies-po-en-1-1536x762.png 1536w\" sizes=\"auto, (max-width: 1896px) 100vw, 1896px\" \/><\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start Trading Pfizer Stock Today \ud83d\udcc9\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>Conclusion: What\u2019s Next for PFE?<\/h2>\n<p>Pfizer stock remains under pressure due to a combination of lost COVID revenue, patent cliffs, and merger-related losses. However, the company retains a stable balance sheet and is investing heavily in R&amp;D.<\/p>\n<p>Why is Pfizer stock so low? The answer lies in both external market shifts and internal strategic headwinds.<\/p>\n<p><strong>What to consider:<\/strong><\/p>\n<ul>\n<li>Dividend yield and long-term stability<\/li>\n<li>High short-term volatility risk<\/li>\n<li>Pipeline progress will be key for recovery<\/li>\n<\/ul>\n<p>Pocket Option allows traders to monitor these assets in real time and act on short-term movements with flexible trade setups.<\/p>\n"},"faq":[{"question":"Why is Pfizer stock so low?","answer":"Due to a sharp drop in COVID revenue, upcoming patent expirations, and weak near-term results from new drugs."},{"question":"Is a Pfizer rebound expected?","answer":"Partially \u2014 if new product development succeeds and earnings stabilize. A return to pandemic-era highs may take years."},{"question":"Is Pfizer\u2019s dividend safe?","answer":"Yes, for now. The payout ratio is manageable, and dividend growth continues."},{"question":"Can I trade Pfizer on Pocket Option?","answer":"Yes, it's available via Quick Trading, Express, and MetaTrader with technical tools and signals."},{"question":"Is there an alternative to buying Pfizer shares?","answer":"Yes \u2014 you can forecast price movements without owning shares using Pocket Option's platform."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Why is Pfizer stock so low?","answer":"Due to a sharp drop in COVID revenue, upcoming patent expirations, and weak near-term results from new drugs."},{"question":"Is a Pfizer rebound expected?","answer":"Partially \u2014 if new product development succeeds and earnings stabilize. A return to pandemic-era highs may take years."},{"question":"Is Pfizer\u2019s dividend safe?","answer":"Yes, for now. The payout ratio is manageable, and dividend growth continues."},{"question":"Can I trade Pfizer on Pocket Option?","answer":"Yes, it's available via Quick Trading, Express, and MetaTrader with technical tools and signals."},{"question":"Is there an alternative to buying Pfizer shares?","answer":"Yes \u2014 you can forecast price movements without owning shares using Pocket Option's platform."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Why is Pfizer Stock So Low: Analyzing the Decline of PFE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why is Pfizer Stock So Low: Analyzing the Decline of PFE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-01T05:40:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-14T07:55:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Tatiana OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatiana OK\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\"},\"author\":{\"name\":\"Tatiana OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"headline\":\"Why is Pfizer Stock So Low: Analyzing the Decline of PFE\",\"datePublished\":\"2025-08-01T05:40:00+00:00\",\"dateModified\":\"2025-08-14T07:55:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\"},\"wordCount\":11,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp\",\"keywords\":[\"investment\",\"stock\",\"strategy\"],\"articleSection\":[\"Trading\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\",\"name\":\"Why is Pfizer Stock So Low: Analyzing the Decline of PFE\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp\",\"datePublished\":\"2025-08-01T05:40:00+00:00\",\"dateModified\":\"2025-08-14T07:55:00+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why is Pfizer Stock So Low: Analyzing the Decline of PFE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\",\"name\":\"Tatiana OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"caption\":\"Tatiana OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/tatiana\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Why is Pfizer Stock So Low: Analyzing the Decline of PFE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/","og_locale":"en_US","og_type":"article","og_title":"Why is Pfizer Stock So Low: Analyzing the Decline of PFE","og_url":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-01T05:40:00+00:00","article_modified_time":"2025-08-14T07:55:00+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp","type":"image\/webp"}],"author":"Tatiana OK","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatiana OK","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"author":{"name":"Tatiana OK","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"headline":"Why is Pfizer Stock So Low: Analyzing the Decline of PFE","datePublished":"2025-08-01T05:40:00+00:00","dateModified":"2025-08-14T07:55:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"wordCount":11,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp","keywords":["investment","stock","strategy"],"articleSection":["Trading"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/","url":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/","name":"Why is Pfizer Stock So Low: Analyzing the Decline of PFE","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp","datePublished":"2025-08-01T05:40:00+00:00","dateModified":"2025-08-14T07:55:00+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/Visa-Convenience-Fee-Rules-How-They-Influence-Transaction-Costs.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"Why is Pfizer Stock So Low: Analyzing the Decline of PFE"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d","name":"Tatiana OK","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","caption":"Tatiana OK"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/tatiana\/"}]}},"po_author":false,"po__editor":false,"po_last_edited":"","wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":327747,"slug":"why-is-pfizer-stock-so-low","post_title":"Pourquoi l'action Pfizer est-elle si basse : analyse du d\u00e9clin de PFE","href":"https:\/\/pocketoption.com\/blog\/fr\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"it_IT":{"locale":"it_IT","id":327748,"slug":"why-is-pfizer-stock-so-low","post_title":"Perch\u00e9 le Azioni Pfizer Sono Cos\u00ec Basse: Analisi del Declino di PFE","href":"https:\/\/pocketoption.com\/blog\/it\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"pl_PL":{"locale":"pl_PL","id":327750,"slug":"why-is-pfizer-stock-so-low","post_title":"Dlaczego akcje Pfizer s\u0105 tak niskie: Analiza spadku PFE","href":"https:\/\/pocketoption.com\/blog\/pl\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"es_ES":{"locale":"es_ES","id":327745,"slug":"why-is-pfizer-stock-so-low","post_title":"\u00bfPor qu\u00e9 est\u00e1 tan baja la acci\u00f3n de Pfizer: Analizando la ca\u00edda de PFE?","href":"https:\/\/pocketoption.com\/blog\/es\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"th_TH":{"locale":"th_TH","id":327752,"slug":"why-is-pfizer-stock-so-low","post_title":"\u0e17\u0e33\u0e44\u0e21\u0e2b\u0e38\u0e49\u0e19\u0e02\u0e2d\u0e07 Pfizer \u0e16\u0e36\u0e07\u0e15\u0e48\u0e33: \u0e27\u0e34\u0e40\u0e04\u0e23\u0e32\u0e30\u0e2b\u0e4c\u0e01\u0e32\u0e23\u0e25\u0e14\u0e25\u0e07\u0e02\u0e2d\u0e07 PFE","href":"https:\/\/pocketoption.com\/blog\/th\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"tr_TR":{"locale":"tr_TR","id":327749,"slug":"why-is-pfizer-stock-so-low","post_title":"Pfizer Hissesi Neden Bu Kadar D\u00fc\u015f\u00fck: PFE'nin D\u00fc\u015f\u00fc\u015f\u00fcn\u00fc Analiz Etmek","href":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"vt_VT":{"locale":"vt_VT","id":327751,"slug":"why-is-pfizer-stock-so-low","post_title":"T\u1ea1i sao c\u1ed5 phi\u1ebfu Pfizer l\u1ea1i th\u1ea5p: Ph\u00e2n t\u00edch s\u1ef1 suy gi\u1ea3m c\u1ee7a PFE","href":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"},"pt_AA":{"locale":"pt_AA","id":327746,"slug":"why-is-pfizer-stock-so-low","post_title":"Por que as A\u00e7\u00f5es da Pfizer Est\u00e3o T\u00e3o Baixas: Analisando o Decl\u00ednio da PFE","href":"https:\/\/pocketoption.com\/blog\/pt\/knowledge-base\/trading\/why-is-pfizer-stock-so-low\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/327744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=327744"}],"version-history":[{"count":2,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/327744\/revisions"}],"predecessor-version":[{"id":333774,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/327744\/revisions\/333774"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/327308"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=327744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=327744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=327744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}